Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes

Objective. Anakinra is approved for the treatment of RA and cryopyrin-associated periodic syndromes (CAPS). While the anakinra safety profile is well established in RA, the long-term safety profile in severe CAPS is less well documented and will therefore be discussed in this report. Methods. A pros...

Descripción completa

Detalles Bibliográficos
Autores principales: Kullenberg, Torbjörn, Löfqvist, Malin, Leinonen, Mika, Goldbach-Mansky, Raphaela, Olivecrona, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957676/
https://www.ncbi.nlm.nih.gov/pubmed/27143789
http://dx.doi.org/10.1093/rheumatology/kew208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957676/
https://www.ncbi.nlm.nih.gov/pubmed/27143789
http://dx.doi.org/10.1093/rheumatology/kew208

Ejemplares similares